Differences in pteridine urinary levels in patients with malignant and benign ovarian tumors in comparison with healthy individuals

Screening of neoplastic diseases by statistical analysis of urine fluorescence spectroscopic data. Application of multivariate techniques for enhancing classification

The composition of human fluids is modified during the course of neoplastic diseases. Urine analysis offers the advantage of being a noninvasive method for which samples are easily and routinely collected from patients. In this work, urine fluorescence spectra recorded upon excitation at 405 nm were obtained from healthy volunteers and individuals with different oncologic pathologies. A large number of indexes, i.e., parameters obtained from spectral data which assist spectral features characterization, were developed to classify healthy and pathological populations. The discrimination ability of simple predictive indexes, obtained from spectra pretreated with different normalization procedures and by taking their derivatives, was statistically assessed. In addition, multivariate methods, such as principal component analysis and multivariate curve resolution by alternating least squares, were used to develop more elaborate indexes for distinguishing between healthy and pathological populations. All indexes were systematically evaluated on a statistical basis by in lab-developed routines capable of detecting outliers, judging the normal distribution of the indexes, evaluating variance homogeneity, testing the difference between the means of healthy and pathological populations, as well as performing a receiver operator curve analysis to assess the classification power of each index. Those indexes with the best performances were further combined to perform a linear discriminant analysis, which yielded a powerful classification algorithm with an area under the receiver operator curve of 0.986, a sensitivity of 97.7%, a specificity of 100%, and an overall accuracy of 98.8%. The present study shows that the statistical analysis of urine fluorescence data with a proper combination of multivariate techniques bears a high potential to develop massive screening tests for the early detection of oncologic pathologies.

Identification and age-dependence of pteridines in bed bugs (Cimex lectularius) and bat bugs (C. pipistrelli) using liquid chromatography-tandem mass spectrometry

Determining the age of free-living insects, particularly of blood-sucking species, is important for human health because such knowledge critically influences the estimates of biting frequency and vectoring ability. Genetic age determination is currently not available. Pteridines gradually accumulate in the eyes of insects and their concentrations is the prevailing method. Despite of their stability, published extractions differ considerably, including for standards, for mixtures of pteridines and even for light conditions. This methodological inconsistency among studies is likely to influence age estimates severely and to hamper their comparability. Therefore we reviewed methodological steps across 106 studies to identify methodological denominators and results across studies. Second, we experimentally test how different pteridines vary in their age calibration curves in, common bed (Cimex lectularius) and bat bugs (C. pipistrelli). Here we show that the accumulation of particular pteridines varied between a) different populations and b) rearing temperatures but not c) with the impact of light conditions during extraction or d) the type of blood consumed by the bugs. To optimize the extraction of pteridines and measuring concentrations, we recommend the simultaneous measurement of more than one standard and subsequently to select those that show consistent changes over time to differentiate among age cohorts.

The role of urinary pteridines as disease biomarkers

Pteridines and their derivatives function as intermediates in the metabolism of several vitamins and cofactors, and their relevance to disease has inspired new efforts to study their roles as disease biomarkers. Recent analytical advances, such as the emergence of sensitive mass spectrometry techniques, new workflows for measuring pteridine derivatives in their native oxidation states and increased multiplexing capacities for the simultaneous determination of many pteridine derivatives, have enabled researchers to explore the roles of urinary pteridines as disease biomarkers at much lower levels with greater accuracy than with previous technologies or methods. As a result, urinary pteridines are being increasingly studied as putative cancer biomarkers with promising results being reported from exploratory studies. In addition, the role of urinary neopterin as a universal biomarker for immune system activation is being investigated in new diseases where it is anticipated to become a useful supplementary marker in clinical diagnostic settings. In summary, this review provides an overview of recent developments in the clinical study of urinary pteridines as disease biomarkers, covers the most promising aspects of advanced analytical techniques being developed for the determination of urinary pteridines and discusses the major challenges associated with implementing pteridine biomarkers in clinical laboratory settings.